Initial results of an ongoing trial of patients with chronic hepatitis B and traditional risk factors associated with tenofovir disoproxil fumarate use were recently presented at Digestive Disease Week...
Following an analysis of 533 patients with chronic HBV, researchers believe that they have identified various predictors of the risk for liver fibrosis in this patient population.
New data from a global study of 120 countries has provided updated information regarding the prevalence of hepatitis B virus around the world and the effects of treatment on disease burden.
Previous studies have indicated that some patients with HBV and HCV co-infection treated with direct-acting antivirals may have a higher risk than others for HBV reactivation. Researchers aimed to explore...
To help improve HBV care, the American College of Physicians and Centers for Disease Control and Prevention have developed new best practice guidance for hepatitis B vaccination and screening.
In a recent study, researchers assessed the effects of chronic hepatitis B infection on the quality and functionality of sperm. For details, including differences in sperm concentration, motility, and...
A recent study assessed reactivation rates of hepatitis B among patients with inflammatory arthritis and resolved or chronic HBV infection who were taking disease-modifying anti-rheumatic drugs.
